Clinical trial
ACTH Treatment of APOL1- Associated Nephropathy
NCT02006849 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ACTH Treatment of APOL1- Associated Nephropathy
- Lead sponsor
- Wake Forest University Health Sciences
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- January 31, 2014
- Completion date
- January 31, 2019
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
kidney disease